Systemic therapy for colorectal cancer.
نویسندگان
چکیده
N Engl J Med 2005;352:476-87. Copyright © 2005 Massachusetts Medical Society. olorectal cancer is the third most common malignant disease and the second most frequent cause of cancer-related death in the United States, with 145,290 new cases and 56,290 deaths anticipated in 2005. 1 Worldwide, colorectal cancer is the fourth most commonly diagnosed malignant disease, with an estimated 1,023,000 new cases and 529,000 deaths each year. 2
منابع مشابه
Singapore Cancer Network (SCAN) Guidelines for Systemic Therapy of Colorectal Cancer.
INTRODUCTION The SCAN colorectal cancer systemic therapy workgroup aimed to develop Singapore Cancer Network (SCAN) clinical practice guidelines for systemic therapy for colorectal cancer in Singapore. MATERIALS AND METHODS The workgroup utilised a modified ADAPTE process to calibrate high quality international evidence-based clinical practice guidelines to our local setting. RESULTS Five i...
متن کاملSingapore Cancer Network (SCAN) Guidelines for Systemic Therapy of Colorectal Cancer
Introduction: The SCAN colorectal cancer systemic therapy workgroup aimed to develop Singapore Cancer Network (SCAN) clinical practice guidelines for systemic therapy for colorectal cancer in Singapore. Materials and Methods: The workgroup utilised a modifi ed ADAPTE process to calibrate high quality international evidence-based clinical practice guidelines to our local setting. Results: Five i...
متن کاملMetastatic Colorectal Cancer: Optimizing Treatment with Anti-EGFR Monoclonal Antibody
Colorectal cancer remains a major cause of morbidity and mortality worldwide despite substantial improvement in the standard of care. Although surgical resection in selected patients may potentially be curative, systemic therapy is the only choice of treatment for most patients with metastatic colorectal cancer. Anti-epidermal growth factor receptor (anti-EGFR) monoclonal antibody has establish...
متن کاملSystemic Targeted Alpha Radiotherapy for Cancer
Background: The fundamental principles of internal targeted alpha therapy for cancer were established many decades ago.The high linear energy transfer (LET) of alpha radiation to the targeted cancer cellscauses double strand breaks in DNA. At the same time, the short range radiation spares adjacent normal tissues. This targeted approach complements conventional external beam radiotherapy and ch...
متن کاملPersonalized medicine in colorectal cancer: the evidence so far
Colorectal cancer is the third most common cancer worldwide and the fourth most common cause of cancer-related death. Current treatment continues to mostly be determined by stratifying patients into fairly broad groups, according to prognosis based on clinicopathological and histopathological staging. Conventional chemotherapy remains the mainstay of systemic treatment, with no established mean...
متن کاملCurrent strategies in previously untreated advanced colorectal cancer.
Colorectal cancer is the second most common cause of cancer-related death in the United States. Approximately 30% to 40% of patients with colorectal cancer have locoregionally advanced or metastatic disease on presentation and cannot be cured with surgical therapy. After many years without significant change, systemic therapy for colorectal cancer is rapidly evolving. The past decade has seen t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The New England journal of medicine
دوره 352 5 شماره
صفحات -
تاریخ انتشار 2005